Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Tam-McDevitt

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Oncology (Williston Park, N.Y.)|September 10, 2008
Polypharmacy, aging, and cancerJennifer Tam-McDevitt
Journal of the National Cancer Institute|September 25, 2008
Re: Cost of care for the elderly cancer patients in the United StatesLodovico Balducci, Jennifer Tam-McDevitt, Robert Hauser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Long overdue: phase II studies in older cancer patients: where does the FDA stand?Lodovico Balducci, Jennifer Tam-McDevitt, Robert Hauser, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Oncology (Williston Park, N.Y.)|September 10, 2008
Polypharmacy, aging, and cancerJennifer Tam-McDevitt
Journal of the National Cancer Institute|September 25, 2008
Re: Cost of care for the elderly cancer patients in the United StatesLodovico Balducci, Jennifer Tam-McDevitt, Robert Hauser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Long overdue: phase II studies in older cancer patients: where does the FDA stand?Lodovico Balducci, Jennifer Tam-McDevitt, Robert Hauser, et al.
Pageof 1